Teva has agreed to pay a whopping $1.2 billion to settle a US lawsuit claiming its subsidiary Cephalon paid to hold up generic competition to its narcolepsy therapy Provigil.

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

If you buy something, we may earn an affiliate commission. We spoke to Dr. Daughtry and Dr. Smith about how to find shoes that’ll relieve your discomfort, then rounded up the best options you ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

After hours: 7:38:15 p.m. EST ...

After testing numerous pairs of workout shoes over the past decade, I’ve learned that gym shoes have to strike the right balance of support and versatility. Wear the wrong ones and your entire ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy ...

Spring is not a welcome season for me. I wanted to find a better way, so I bought one of these units. Then I bought another, ...